I. Boroňová and J. Bernasovská and J. Kmec and E. Petrejčíková
ZBTB17 Gene rs10927875 Polymorphism in Slovak Patients with Dilated Cardiomyopathy
562 - 565
2014
8
9
International Journal of Bioengineering and Life Sciences
https://publications.waset.org/pdf/9999352
https://publications.waset.org/vol/93
World Academy of Science, Engineering and Technology
Dilated cardiomyopathy (DCM) is a severe
cardiovascular disorder characterized by progressive systolic
dysfunction due to cardiac chamber dilatation and inefficient
myocardial contractility often leading to chronic heart failure.
Recently, a genomewide association studies (GWASs) on DCM
indicate that the ZBTB17 gene rs10927875 single nucleotide
polymorphism is associated with DCM. The aim of the study was to
identify the distribution of ZBTB17 gene rs10927875 polymorphism
in 50 Slovak patients with DCM and 80 healthy control subjects
using the Custom Taqman®SNP Genotyping assays. Risk factors
detected at baseline in each group included age, sex, body mass
index, smoking status, diabetes and blood pressure. The mean age of
patients with DCM was 52.9±6.3 years; the mean age of individuals
in control group was 50.3±8.9 years. The distribution of investigated
genotypes of rs10927875 polymorphism within ZBTB17 gene in the
cohort of Slovak patients with DCM was as follows CC (38.8), CT
(55.1), TT (6.1), in controls CC (43.8), CT (51.2), TT
(5.0). The risk allele T was more common among the patients with
dilated cardiomyopathy than in normal controls (33.7 versus
30.6). The differences in genotype or allele frequencies of ZBTB17
gene rs10927875 polymorphism were not statistically significant
(p0.6908; p0.6098). The results of this study suggest that ZBTB17
gene rs10927875 polymorphism may be a risk factor for
susceptibility to DCM in Slovak patients with DCM. Studies of
numerous files and additional functional investigations are needed to
fully understand the roles of genetic associations.
Open Science Index 93, 2014